Experience

PreciHealth

• Switzerland
• Medical Equipment Manufacturing
• 1 - 100 Employee

• Chairman

  • 2018 - - الحالي

  PreciHealth is focused on developing the world’s first and only self-authenticating auto-injectors and blood collectors. A Swiss company founded in 2017 as a medical spinoff of Preciflex, a leading enterprise that offers creative engineering solutions in the fields of micromechanics and microfluidics; successfully applied Swiss precision to the rapidly growing auto-injectors and blood collection healthcare markets. Intellectual property combines micromechanics and microfluidics technologies, in the design of game-changing micro-sized devices that deliver painless, fast and safe procedures. End-to-end solution transformS the way in which Health Maintenance Organizations deliver care, enabling them to conduct mass population treatments, vaccinations and blood screenings. Mission is to improve global health by enabling individuals to easily, safely and securely self-administer medication and sample their blood in the comfort of their home.



SedateUK

• Medical Practices

• Board Member & Faculty

  • 2015 - - الحالي

  SedateUK is leading, establishing and promoting the skills and competencies necessary for non-anaesthetist healthcare practitioners to administer sedation for diagnostic, interventional and surgical procedures in the UK and beyond. SedateUK is leading, establishing and promoting the skills and competencies necessary for non-anaesthetist healthcare practitioners to administer sedation for diagnostic, interventional and surgical procedures in the UK and beyond.



Herantis Pharma Plc.

• Finland
• Biotechnology Research
• 1 - 100 Employee

• Chief Executive Officer

  • ‏يوليو 2020 - ‏يوليو 2022

  Herantis focuses on disease modifying therapies for debilitating neurodegenerative diseases by restoring the neuronal protective mechanism of proteostasis, a key system in neurodegenerative disease. Proteostasis regulates proteins within the body and influences the fate of every protein from synthesis to degradation. Its failure results in a vicious cycle of pathological accumulation of protein aggregates, neuroinflammation and various forms of cellular stress that is widely implicated with the development of many neurodegenerative diseases including Parkinson’s Disease, Alzheimer’s and other diseases. CDNF (a biological protein) is Herantis’ lead program and a clinical stage asset; and xCDNF (HER-096) (a synthetic peptide version of CDNF) is Herantis’ follow-on program. CDNF is a natural protein that occurs naturally in the body whose natural role is to protect neurons by balancing and supporting proteostasis, thereby preventing and counteracting disease generating mechanisms. Herantis is taking this natural ability and harnessing it as a treatment for neurodegenerative disease. Both CDNF and xCDNF (HER-096), via their multimodal mechanism of action, have the potential to improve neuronal survival and stop the progression of Parkinson’s and other neurodegenerative diseases with a significant therapeutic impact on the quality of patients’ lives. The shares of Herantis are listed on the Nasdaq First North Growth Market Finland and Nasdaq First North Growth Market Sweden



Midatech Pharma PLC

• United Kingdom
• Biotechnology Research
• 1 - 100 Employee

• CEO

  • ‏مارس 2018 - ‏مارس 2020

  Midatech Pharma is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. Driven by a team of scientists, engineers, and pharmaceutical development specialists, and led by an experienced management team, Midatech is progressing a pipeline of differentiated therapeutics in areas of high unmet need for the benefit of patients. Midatech Pharma is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. Driven by a team of scientists, engineers, and pharmaceutical development specialists, and led by an experienced management team, Midatech is progressing a pipeline of differentiated therapeutics in areas of high unmet need for the benefit of patients.



Midatech Ltd

• Biotechnology
• 1 - 100 Employee

• COO & CMO

  • ‏ديسمبر 2013 - ‏مايو 2018

  Midatech Pharma is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. Driven by a team of scientists, engineers, and pharmaceutical development specialists, and led by an experienced management team, Midatech is progressing a pipeline of differentiated therapeutics in areas of high unmet need for the benefit of patients. Midatech Pharma is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. Driven by a team of scientists, engineers, and pharmaceutical development specialists, and led by an experienced management team, Midatech is progressing a pipeline of differentiated therapeutics in areas of high unmet need for the benefit of patients.



Ippon Capital

• Life Sciences Advisor Lead

  • ‏يناير 2008 - ‏ديسمبر 2013



SpaceCode Healthcare Technologies

• CEO

  • ‏يناير 2005 - ‏يناير 2012



Merck Healthcare

• Germany
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Global Medical Affairs Director New Therapies

  • ‏أبريل 2003 - ‏أبريل 2005



Novartis

• Switzerland
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Project Director, Global Head eClinical

  • ‏يناير 2001 - ‏مارس 2003



Eli Lilly and Company

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Strategy Associate

  • ‏يناير 1999 - ‏يناير 2001